Christopher Brightman

581 total citations
13 papers, 365 citations indexed

About

Christopher Brightman is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology. According to data from OpenAlex, Christopher Brightman has authored 13 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Epidemiology and 3 papers in Parasitology. Recurrent topics in Christopher Brightman's work include Financial Markets and Investment Strategies (2 papers), Streptococcal Infections and Treatments (2 papers) and Research on Leishmaniasis Studies (2 papers). Christopher Brightman is often cited by papers focused on Financial Markets and Investment Strategies (2 papers), Streptococcal Infections and Treatments (2 papers) and Research on Leishmaniasis Studies (2 papers). Christopher Brightman collaborates with scholars based in United Kingdom, United States and Russia. Christopher Brightman's co-authors include Stefano Cavaglia, David A. Evans, Vitali Kalesnik and Robert D. Arnott and has published in prestigious journals such as Transactions of the Royal Society of Tropical Medicine and Hygiene, Financial Analysts Journal and Trends in Urology & Men s Health.

In The Last Decade

Christopher Brightman

12 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Brightman United Kingdom 5 278 204 124 90 28 13 365
Callum Jones United States 12 101 0.4× 202 1.0× 136 1.1× 43 0.5× 10 0.4× 34 343
C. A. Johnson United States 7 212 0.8× 115 0.6× 73 0.6× 133 1.5× 15 0.5× 47 300
Maik H. Wolters Germany 12 124 0.4× 285 1.4× 277 2.2× 18 0.2× 8 0.3× 35 422
Roberto Pancrazi United Kingdom 8 211 0.8× 315 1.5× 295 2.4× 22 0.2× 10 0.4× 15 444
Lamin Leigh United States 11 141 0.5× 208 1.0× 139 1.1× 78 0.9× 36 1.3× 25 373
Vasiliki Makri Greece 4 265 1.0× 176 0.9× 25 0.2× 261 2.9× 21 0.8× 10 389
Hsin‐Yi Lin Taiwan 5 149 0.5× 223 1.1× 80 0.6× 23 0.3× 5 0.2× 7 322
John Hund United States 9 298 1.1× 223 1.1× 28 0.2× 181 2.0× 52 1.9× 23 432
Álvaro Ortiz Spain 7 60 0.2× 155 0.8× 70 0.6× 47 0.5× 11 0.4× 13 232
Marielle de Jong France 7 194 0.7× 133 0.7× 50 0.4× 80 0.9× 51 1.8× 27 260

Countries citing papers authored by Christopher Brightman

Since Specialization
Citations

This map shows the geographic impact of Christopher Brightman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brightman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brightman more than expected).

Fields of papers citing papers by Christopher Brightman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Brightman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brightman. The network helps show where Christopher Brightman may publish in the future.

Co-authorship network of co-authors of Christopher Brightman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Brightman. A scholar is included among the top collaborators of Christopher Brightman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Brightman. Christopher Brightman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Arnott, Robert D., et al.. (2023). Earning Alpha by Avoiding the Index Rebalancing Crowd. Financial Analysts Journal. 79(2). 76–97. 2 indexed citations
2.
Brightman, Christopher. (2021). Syphilis: the great mimic. Trends in Urology & Men s Health. 12(1). 26–29.
3.
Brightman, Christopher. (2021). Clostridial infections: diagnosis and management. Trends in Urology & Men s Health. 12(5). 27–32. 2 indexed citations
4.
Brightman, Christopher, et al.. (2020). Melioidosis: the Vietnamese time bomb. Trends in Urology & Men s Health. 11(3). 30–32. 6 indexed citations
5.
Brightman, Christopher. (2019). Plague and anthrax: diagnosis and management. Trends in Urology & Men s Health. 10(3). 27–30. 1 indexed citations
6.
Brightman, Christopher. (2018). Leptospirosis: a leisure and occupational hazard. Trends in Urology & Men s Health. 9(1). 29–31. 6 indexed citations
7.
Brightman, Christopher. (2018). Tetanus: an ever‐present infection risk. Trends in Urology & Men s Health. 9(3). 29–31. 1 indexed citations
8.
Brightman, Christopher. (2017). Lead poisoning: rare but be aware. Trends in Urology & Men s Health. 8(6). 29–31. 2 indexed citations
9.
Brightman, Christopher. (2015). Typhoid fever: yesterday, today and unfortunately still tomorrow. Trends in Urology & Men s Health. 6(6). 17–20. 1 indexed citations
10.
Brightman, Christopher. (2012). Rabies: an acute viral infection. Trends in Urology & Men s Health. 3(5). 31–33. 4 indexed citations
11.
Brightman, Christopher. (2011). Schistosomiasis. Trends in Urology & Men s Health. 2(5). 38–42. 2 indexed citations
12.
Cavaglia, Stefano, et al.. (2000). The Increasing Importance of Industry Factors. Financial Analysts Journal. 56(5). 41–54. 318 indexed citations
13.
Evans, David A. & Christopher Brightman. (1980). Pleomorphism and the problem of recrudescent parasitaemia following treatment with salicylhydroxamic acid (SHAM) in African trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 74(5). 601–604. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026